<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00762528</url>
  </required_header>
  <id_info>
    <org_study_id>CRO-1107-INF-ECU-FP</org_study_id>
    <nct_id>NCT00762528</nct_id>
  </id_info>
  <brief_title>Compare Anti-inflammatory Dentifrices</brief_title>
  <official_title>Compare Anti-inflammatory Dentifrices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Colgate Palmolive</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Colgate Palmolive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Plaque induced gingivitis
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gingival Index (GI)</measure>
    <time_frame>29 days</time_frame>
    <description>Gingival Index(GI)recorded on scale of 0-3 detailed below:
0=normal gingiva, 1=Mild inflammation(slight change in color, slight edema)no bleeding on palpation,2=Moderate inflammation(redness,edema,glazing)bleeding upon probing, 3=Severe inflammation(marked redness,edema)ulceration &amp; tendency to spontaneously bleed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prostaglandin E2 (PGE2)</measure>
    <time_frame>29 days</time_frame>
    <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Higher Levels found in GCF may be a factor in tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interleukin - 1 Beta (IL-ß)</measure>
    <time_frame>29 days</time_frame>
    <description>Inflammatory biomarkers found in gingival crevicular fluid (GCF) that may be a factor in oral tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interleukin-6 (IL-6)</measure>
    <time_frame>29 days</time_frame>
    <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Higher Levels found in GCF may be a factor in tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nuclear Factor Kappa B Ligand (RANK-L)</measure>
    <time_frame>29 days</time_frame>
    <description>Receptor activator found in gingival crevicular fluid (GCF). Presence in GCF may indicate tissue damage as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>8-iso-prostaglandinF2α (8-iso-PGF2α)</measure>
    <time_frame>29 days</time_frame>
    <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Presence in GCF may indicate tissue damage as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dental Plaque Index (PI)</measure>
    <time_frame>29 days</time_frame>
    <description>measurement of supragingival dental plaque on scale of 0-3. 0=No plaque in gingival area,1=a film of plaque adhering to the free gingival margin and the adjacent tooth,2=Moderate accumulation of soft deposits within the gingival pocket and on the gingival margin and/or adjacent tooth-visible by the naked eye, 3=Abundance of soft matter within the gingival pocket and/or gingival margin and adjacent tooth surfaces.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on Probing (BOP)</measure>
    <time_frame>29 days</time_frame>
    <description>Presence or absence of bleeding to manual probing as a dichotomous variable as follows: 0 = No bleeding within 10 seconds after probing, 1 = Bleeding within 10 seconds after probing.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>Total Toothpaste</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Triclosan/Copolymer/fluoride toothpaste</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fluoride toothpaste</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>sodium monofluorophosphate toothpaste</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triclosan/Copolymer/fluoride toothpaste</intervention_name>
    <description>Twice daily usage</description>
    <arm_group_label>Total Toothpaste</arm_group_label>
    <other_name>Toothpaste includes triclosan/fluoride/co-polymer (Total)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium monofluorophosphate toothpaste</intervention_name>
    <description>Twice daily usage</description>
    <arm_group_label>Fluoride toothpaste</arm_group_label>
    <other_name>fluoride only toothpaste</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be adult males or females 18 to 60 years old

          -  Subjects must be able and willing to follow study procedures and instructions

          -  Subjects must have read, understood and signed an informed consent form

          -  Subjects must have generalized, moderate plaque-associated gingivitis as determined by
             the Investigator or designee during the screening examination

          -  Subjects must present with at least 20 teeth in the functional dentition, excluding
             third molars

          -  Each subject must have at least four teeth with probing depths of 4-5 mm and at least
             30% of sites bleeding to gentle probing

        Exclusion Criteria:

          -  Subjects who have chronically used (i.e., two weeks or more) Total
             (Triclosan/Copolymer) dentifrice within 6 months prior to enrollment

          -  Subjects with gross oral pathology, including widespread caries or chronic neglect,
             extensive restoration, pre-existing gross plaque and calculus, or soft or hard tissue
             tumor of the oral cavity

          -  Subjects with periodontitis as indicated by periodontal pocketing 6 mm at screening

          -  Subjects with a history of early onset periodontitis or acute necrotizing ulcerative
             gingivitis

          -  Subjects with concomitant endodontic or periodontal therapy other than prophylaxis
             within 6 months prior to enrollment

          -  Subjects with orthodontic appliances or removable partial dentures

          -  Subjects chronically treated (two weeks or more) with any medication known to affect
             inflammation or periodontal status or (aspirin, nonsteroidal anti-inflammatory drugs,
             steroids, statins, phenytoin, calcium antagonists, cyclosporin and coumadin) within
             one month of the screening examination. All other medications for chronic medical
             conditions should be initiated at least three months prior to enrollment

          -  Subjects who currently smoke or who report using tobacco products within one year of
             screening.

          -  Subjects who have been treated with antibiotics for medical or dental reasons within 3
             months prior to enrollment

          -  Subjects having clinically significant or unstable organic disease; subjects having
             compromised healing potential such as those with diabetes mellitus or connective
             tissue disorders; subjects having heart murmurs, histories of rheumatic fever,
             valvular disease or prosthetic joint replacement necessitating antibiotic prophylaxis

          -  Female subjects who report being pregnant or lactating, or female subjects who are of
             childbearing potential and who report not using hormonal or barrier methods of birth
             control (oral or parenteral contraceptives, diaphragm plus spermicide, condoms)

          -  Subjects who use hormonal contraceptives must have started the method 30 days prior to
             the screening examination.

          -  Subjects with active infectious diseases such as hepatitis, human immunodeficiency
             virus or Tuberculosis

          -  Subjects diagnosed with human immunodeficiency virus (HIV) or subjects that are
             immunocompromised as determined by the Investigator

          -  Medical condition which precludes not eating/drinking for approximately 8 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara G Grossi, DDS</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>East Carolina University, Brody School of Medicine</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2008</study_first_submitted>
  <study_first_submitted_qc>September 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <results_first_submitted>March 5, 2012</results_first_submitted>
  <results_first_submitted_qc>March 5, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 3, 2012</results_first_posted>
  <last_update_submitted>August 27, 2015</last_update_submitted>
  <last_update_submitted_qc>August 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Fluorophosphate</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
    <mesh_term>Triclosan</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>subject recruitment will be completed by the PI at the clinical site.</recruitment_details>
      <pre_assignment_details>Subjects are screened for plaque, bleeding and gingivitis scores before being assigned to any Study Treatment. Study Treatment randomization is balanced across the two treatment groups and is accomplished by stratification of subjects by gender (male &amp; female) and baseline gingivitis (GI) scores.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Total Toothpaste</title>
          <description>Triclosan/Copolymer/fluoride toothpaste</description>
        </group>
        <group group_id="P2">
          <title>Fluoride Toothpaste</title>
          <description>Sodium monofluorophosphate toothpaste</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Total Toothpaste</title>
          <description>Triclosan/Copolymer/fluoride toothpaste</description>
        </group>
        <group group_id="B2">
          <title>Fluoride Toothpaste</title>
          <description>sodium monofluorophosphate toothpaste</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.5" spread="10.7"/>
                    <measurement group_id="B2" value="29.2" spread="9.6"/>
                    <measurement group_id="B3" value="28.4" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Gingival Index (GI)</title>
        <description>Gingival Index(GI)recorded on scale of 0-3 detailed below:
0=normal gingiva, 1=Mild inflammation(slight change in color, slight edema)no bleeding on palpation,2=Moderate inflammation(redness,edema,glazing)bleeding upon probing, 3=Severe inflammation(marked redness,edema)ulceration &amp; tendency to spontaneously bleed</description>
        <time_frame>29 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Total Toothpaste</title>
            <description>Triclosan/Copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Fluoride Toothpaste</title>
            <description>sodium monofluorophosphate toothpaste</description>
          </group>
        </group_list>
        <measure>
          <title>Gingival Index (GI)</title>
          <description>Gingival Index(GI)recorded on scale of 0-3 detailed below:
0=normal gingiva, 1=Mild inflammation(slight change in color, slight edema)no bleeding on palpation,2=Moderate inflammation(redness,edema,glazing)bleeding upon probing, 3=Severe inflammation(marked redness,edema)ulceration &amp; tendency to spontaneously bleed</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.04" spread="0.22"/>
                    <measurement group_id="O2" value="1.01" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Prostaglandin E2 (PGE2)</title>
        <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Higher Levels found in GCF may be a factor in tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
        <time_frame>29 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Total Toothpaste</title>
            <description>Triclosan/Copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Fluoride Toothpaste</title>
            <description>sodium monofluorophosphate toothpaste</description>
          </group>
        </group_list>
        <measure>
          <title>Prostaglandin E2 (PGE2)</title>
          <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Higher Levels found in GCF may be a factor in tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
          <units>pg/µl</units>
          <param>Log Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" spread="2.7"/>
                    <measurement group_id="O2" value="5.2" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Interleukin - 1 Beta (IL-ß)</title>
        <description>Inflammatory biomarkers found in gingival crevicular fluid (GCF) that may be a factor in oral tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
        <time_frame>29 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Total Toothpaste</title>
            <description>Triclosan/Copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Fluoride Toothpaste</title>
            <description>sodium monofluorophosphate toothpaste</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin - 1 Beta (IL-ß)</title>
          <description>Inflammatory biomarkers found in gingival crevicular fluid (GCF) that may be a factor in oral tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
          <units>pg/µl</units>
          <param>Log Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="0.8"/>
                    <measurement group_id="O2" value="6.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dental Plaque Index (PI)</title>
        <description>measurement of supragingival dental plaque on scale of 0-3. 0=No plaque in gingival area,1=a film of plaque adhering to the free gingival margin and the adjacent tooth,2=Moderate accumulation of soft deposits within the gingival pocket and on the gingival margin and/or adjacent tooth-visible by the naked eye, 3=Abundance of soft matter within the gingival pocket and/or gingival margin and adjacent tooth surfaces.</description>
        <time_frame>29 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Total Toothpaste</title>
            <description>Triclosan/Copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Fluoride Toothpaste</title>
            <description>sodium monofluorophosphate toothpaste</description>
          </group>
        </group_list>
        <measure>
          <title>Dental Plaque Index (PI)</title>
          <description>measurement of supragingival dental plaque on scale of 0-3. 0=No plaque in gingival area,1=a film of plaque adhering to the free gingival margin and the adjacent tooth,2=Moderate accumulation of soft deposits within the gingival pocket and on the gingival margin and/or adjacent tooth-visible by the naked eye, 3=Abundance of soft matter within the gingival pocket and/or gingival margin and adjacent tooth surfaces.</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.69" spread="0.30"/>
                    <measurement group_id="O2" value="1.65" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bleeding on Probing (BOP)</title>
        <description>Presence or absence of bleeding to manual probing as a dichotomous variable as follows: 0 = No bleeding within 10 seconds after probing, 1 = Bleeding within 10 seconds after probing.</description>
        <time_frame>29 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Total Toothpaste</title>
            <description>Triclosan/Copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Fluoride Toothpaste</title>
            <description>sodium monofluorophosphate toothpaste</description>
          </group>
        </group_list>
        <measure>
          <title>Bleeding on Probing (BOP)</title>
          <description>Presence or absence of bleeding to manual probing as a dichotomous variable as follows: 0 = No bleeding within 10 seconds after probing, 1 = Bleeding within 10 seconds after probing.</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.10"/>
                    <measurement group_id="O2" value="0.26" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Interleukin-6 (IL-6)</title>
        <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Higher Levels found in GCF may be a factor in tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
        <time_frame>29 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Total Toothpaste</title>
            <description>Triclosan/Copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Fluoride Toothpaste</title>
            <description>sodium monofluorophosphate toothpaste</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin-6 (IL-6)</title>
          <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Higher Levels found in GCF may be a factor in tissue destruction as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
          <units>pg/µl</units>
          <param>Log Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="0.7"/>
                    <measurement group_id="O2" value="2.7" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Nuclear Factor Kappa B Ligand (RANK-L)</title>
        <description>Receptor activator found in gingival crevicular fluid (GCF). Presence in GCF may indicate tissue damage as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
        <time_frame>29 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Total Toothpaste</title>
            <description>Triclosan/Copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Fluoride Toothpaste</title>
            <description>sodium monofluorophosphate toothpaste</description>
          </group>
        </group_list>
        <measure>
          <title>Nuclear Factor Kappa B Ligand (RANK-L)</title>
          <description>Receptor activator found in gingival crevicular fluid (GCF). Presence in GCF may indicate tissue damage as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
          <units>pg/µl</units>
          <param>Log Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="0.9"/>
                    <measurement group_id="O2" value="4.4" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>8-iso-prostaglandinF2α (8-iso-PGF2α)</title>
        <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Presence in GCF may indicate tissue damage as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
        <time_frame>29 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Total Toothpaste</title>
            <description>Triclosan/Copolymer/fluoride toothpaste</description>
          </group>
          <group group_id="O2">
            <title>Fluoride Toothpaste</title>
            <description>sodium monofluorophosphate toothpaste</description>
          </group>
        </group_list>
        <measure>
          <title>8-iso-prostaglandinF2α (8-iso-PGF2α)</title>
          <description>Inflammatory biomarker found in gingival crevicular fluid (GCF). Presence in GCF may indicate tissue damage as seen in periodontal disease. All GCF samples are collected onto filter paper strips (Pro Flow, Inc.) and the volume determined by Periotron 8000. Samples were placed in cryovial and labelled, then place into liquid nitrogen and stored at -180°C until analysis.</description>
          <units>pg/µl</units>
          <param>Log Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.2" spread="3.8"/>
                    <measurement group_id="O2" value="15.2" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis states that there is no difference between groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>29 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Total Toothpaste</title>
          <description>Triclosan/Copolymer/fluoride toothpaste</description>
        </group>
        <group group_id="E2">
          <title>Fluoride Toothpaste</title>
          <description>sodium monofluorophosphate toothpaste</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Teeth Sensitive to cold</sub_title>
                <description>2 subjects reported tooth sensitivity to cold.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Oral Irritation</sub_title>
                <description>subject reported oral irritation</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>chest cold, upper respiratory infection</sub_title>
                <description>2 subjects reported having a cold</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Pulled muscle in back</sub_title>
                <description>subject reported having a pulled muscle in their back.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Fever, chills &amp; sore throat</sub_title>
                <description>subject reported experiencing a fever, chills and sore throat.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>William DeVizio, DMD</name_or_title>
      <organization>Colgate Palmolive Company</organization>
      <phone>732-878-7901</phone>
      <email>william_Devizio@colpal.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

